Skip to main navigation
Allakos Logo

Investors

SEC Filing Details

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 6, 2023
Document Date
Mar 6, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Allakos
Issuer
Allakos Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT


(Common Stock)


May 27, 2023 3:29 AM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Toolkit

Print Page

Email Page

Email Alerts

RSS Feeds

  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • About
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory
  • Science
    • Overview
    • Biology
    • Siglec-8
    • Siglec-6
    • Lirentelimab (AK002)
    • AK006
    • Scientific Presentations
  • Clinical
    • Overview
    • Lirentelimab in Mast Cell and Eosinophil Driven Diseases
  • Patients
    • Allakos Commitment
    • EGID Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • Financials & Filings
      • SEC Filings
      • Quarterly Reports
      • Annual Reports
    • Stock Information
      • Stock Information
    • Contact
  • Careers
    • Working at Allakos
    • Open Positions
  • Contact
  • About
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory
  • Science
    • Overview
    • Biology
    • Siglec-8
    • Siglec-6
    • Lirentelimab (AK002)
    • AK006
    • Scientific Presentations
  • Clinical
    • Overview
    • Lirentelimab in Mast Cell and Eosinophil Driven Diseases
  • Patients
    • Allakos Commitment
    • EGID Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • Financials & Filings
      • SEC Filings
      • Quarterly Reports
      • Annual Reports
    • Stock Information
      • Stock Information
    • Contact
  • Careers
    • Working at Allakos
    • Open Positions
  • Contact
©  Allakos Inc. All rights reservedWebsite Design: Hane Chow, Inc.
  • Privacy and Cookie Policy
  • Terms of Use